We are transforming pediatric healthcare through the power of Rapid Precision Medicine™.
We’re innovating to expedite personalized treatment of rare genetic disease.
We’re setting a new standard of care for newborns and children with rare undiagnosed diseases.
We're hiring for clinical, research, bioinformatics, and administrative positions.
Babies with Fitz’s condition, commonly known as “bubble boy disease,” rarely survive to toddlerhood. He became one of the first babies anywhere to get a specific diagnosis within days of birth and an experimental therapy several months later that appears to have worked.
In 2021, the Genomic Medicine Working Group of the National Advisory Council for Human Genome Research of NHGRI identified its ten most significant peer-reviewed studies for 2021.
While it is safe to say that RCIGM has sufficiently proven its ability to identify the genetic variants driving many of these life-threatening rare conditions, it is now on a mission to bring its method of diagnosing sick babies to health systems across the country.
Wednesday February 23, 2022 | 3pm PST
*Free Registration is required
Tuesday April 26, 2022 | Wednesday, April 27, 2022
Rapid Precision Medicine™ is here now. We are setting the standard for pediatric critical care by breaking barriers to expand access to genomically-informed, personalized care nationwide. We offer many opportunities to collaborate with as we work to save and improve lives.
© 2022 Rady Children's Institute for Genomic Medicine.
